MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote (mnc pharma)
- NOVARTIS
NOVARTIS Share Price (NVRT)
Here is the latest stock price and chart of Novartis. For more details, see the Novartis company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
| Live BSE Quotes | Apr 9, 2020 (Close) | ||
|---|---|---|---|
| Price (Rs)568.00 | Open (Rs) 580.00 | High (Rs) 588.00 | Low (Rs) 565.00 |
| % Change-0.04 | Volume 28,179 | Value (Rs) 16,173,153 | 52-Week H/L 780.00 / 420.05 |
| Live NSE Quotes |
|---|
| Not listed |
| Valuation | |||
|---|---|---|---|
| EPS (Rs)* 0.68 | P/E Ratio (x) 834.61 | Market Cap (Rs m) 190,541.28 | P/BV (x) 25.10 |
| *Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
- Charts
-
S&P BSE SENSEX 
PERIOD - Advanced Charts new
- Charts by TradingView
NOVARTIS Share Price Today:
NOVARTIS last traded price was down 0.0% to Rs 568.0 on the BSE. The total volume of shares traded was 0.0 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 3.8%. And the benchmark S&P BSE SENSEX was at 31,159.6 (up 4.2%).
Over the last 30 days, the NOVARTIS share price is up 5.3%. And over the last one year, NOVARTIS share price is down 18.0%.
What else is happening in the markets today? Dig in...
- TRACK NOW:
- Most Active Stocks Rs 0 to 10
- Most Active Stocks Rs 10 to 20
- BSE A Group Gainers Today
- NSE Above Rs 20 Gainers Today
- BSE Above Rs 20 Gainers Today
- BSE Sensex Gainers Today
- BSE Small Cap Gainers Today
- BSE 500 Gainers Today
- BSE A Group Losers Today
- Most Active Stocks Rs 1 to 2
- NSE Above Rs 20 Losers Today
- ANALYSE:
- TCS
- HDFC BANK
- ITC LIMITED
- ONGC
- HINDUSTAN UNILEVER
- SBI
Today's Market
Sensex Surges 1,266 Points; Nifty Ends Above 9,100 Mark(Closing)
Indian share markets witnessed buying interest throughout the day and ended on a strong note.
Related Views On News
NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)
Feb 17, 2020 | Updated on Feb 17, 2020For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.
NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)
Aug 13, 2019 | Updated on Aug 13, 2019For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.
More Views on NewsMost Popular
Sorry Warren Buffett, I'm Following This Man Instead of You in 2020 (The 5 Minute Wrapup)
Mar 30, 2020This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...
One Stock that is All Charged Up for the Post Coronavirus Rebound (The 5 Minute Wrapup)
Apr 1, 2020A stock with strong moat is currently trading near 5-year lows.
A Safe Stock to Lockdown Now (The 5 Minute Wrapup)
Apr 2, 2020The market crashc has made strong, established brands attractive. Here's a stock to make the most of this opportunity...
The Insiders See a Buying Opportunity in These Smallcaps Amid Coronavirus Outbreak (Profit Hunter)
Mar 31, 2020The promoters are buying these smallcaps amid the coronavirus outbreak.
This Smallcap Tech Firm has Risen to the Coronavirus Challenge (Profit Hunter)
Apr 7, 2020This smallcap tech firm is all set to emerge stronger from the Coronavirus crisis.
MoreOUR TOP 5 IDEAS
- How to Trade the Coronavirus Crash - Download this FREE Report Now
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
- Free Report: The Secret to Increasing Your Trading Profits Daily!
- Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!
TRACK NOVARTIS
- Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON NOVARTIS
NOVARTIS - NATCO PHARMA COMPARISON
COMPARE NOVARTIS WITH
OTHER USEFUL LINKS
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.